Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

GLP-1s, the popular medications helping millions of people lose weight by curbing their appetites, may not be very high on the list of things ... Circana found that GLP-1 users traditionally ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for alternative ways to administer anti-obesity drugs. The new, compounded offering ...

The company said this drug could be used as a monotherapy or in combination with an oral GLP-1 agonist. The third program is a subcutaneously injected amylin agonist designed to be long-acting.

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

Ezekiel Emanuel and Dr. Ty Gluckman explore trends in patients stopping or restarting GLP-1 medications. This graph shows the time to discontinuation and reinitiation for patients with and without ...